Literature DB >> 26246866

BAYESIAN SPARSE GRAPHICAL MODELS FOR CLASSIFICATION WITH APPLICATION TO PROTEIN EXPRESSION DATA.

Veerabhadran Baladandayuthapani1, Rajesh Talluri1, Yuan Ji2, Kevin R Coombes3, Yiling Lu1, Bryan T Hennessy4, Michael A Davies1, Bani K Mallick5.   

Abstract

Reverse-phase protein array (RPPA) analysis is a powerful, relatively new platform that allows for high-throughput, quantitative analysis of protein networks. One of the challenges that currently limit the potential of this technology is the lack of methods that allow for accurate data modeling and identification of related networks and samples. Such models may improve the accuracy of biological sample classification based on patterns of protein network activation and provide insight into the distinct biological relationships underlying different types of cancer. Motivated by RPPA data, we propose a Bayesian sparse graphical modeling approach that uses selection priors on the conditional relationships in the presence of class information. The novelty of our Bayesian model lies in the ability to draw information from the network data as well as from the associated categorical outcome in a unified hierarchical model for classification. In addition, our method allows for intuitive integration of a priori network information directly in the model and allows for posterior inference on the network topologies both within and between classes. Applying our methodology to an RPPA data set generated from panels of human breast cancer and ovarian cancer cell lines, we demonstrate that the model is able to distinguish the different cancer cell types more accurately than several existing models and to identify differential regulation of components of a critical signaling network (the PI3K-AKT pathway) between these two types of cancer. This approach represents a powerful new tool that can be used to improve our understanding of protein networks in cancer.

Entities:  

Keywords:  Bayesian methods; graphical models; mixture models; protein signaling pathways

Year:  2014        PMID: 26246866      PMCID: PMC4523298          DOI: 10.1214/14-AOAS722

Source DB:  PubMed          Journal:  Ann Appl Stat        ISSN: 1932-6157            Impact factor:   2.083


  40 in total

1.  Extracting active pathways from gene expression data.

Authors:  Jean Philippe Vert; Minoru Kanehisa
Journal:  Bioinformatics       Date:  2003-10       Impact factor: 6.937

2.  Variable slope normalization of reverse phase protein arrays.

Authors:  E Shannon Neeley; Steven M Kornblau; Kevin R Coombes; Keith A Baggerly
Journal:  Bioinformatics       Date:  2009-03-31       Impact factor: 6.937

Review 3.  Point mutations of protein kinases and individualised cancer therapy.

Authors:  Michael Davies; Bryan Hennessy; Gordon B Mills
Journal:  Expert Opin Pharmacother       Date:  2006-11       Impact factor: 3.889

4.  Quantitative proteomic analysis in breast cancer.

Authors:  A Tabchy; B T Hennessy; A M Gonzalez-Angulo; F M Bernstam; Y Lu; G B Mills
Journal:  Drugs Today (Barc)       Date:  2011-02       Impact factor: 2.245

5.  Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set.

Authors:  Eun Sung Park; Rosalia Rabinovsky; Mark Carey; Bryan T Hennessy; Roshan Agarwal; Wenbin Liu; Zhenlin Ju; Wanleng Deng; Yiling Lu; Hyun Goo Woo; Sang-Bae Kim; Jae-Ho Cheong; Levi A Garraway; John N Weinstein; Gordon B Mills; Ju-Seog Lee; Michael A Davies
Journal:  Mol Cancer Ther       Date:  2010-02-02       Impact factor: 6.261

6.  MicroRNA expression profiles for the NCI-60 cancer cell panel.

Authors:  Paul E Blower; Joseph S Verducci; Shili Lin; Jin Zhou; Ji-Hyun Chung; Zunyan Dai; Chang-Gong Liu; William Reinhold; Philip L Lorenzi; Eric P Kaldjian; Carlo M Croce; John N Weinstein; Wolfgang Sadee
Journal:  Mol Cancer Ther       Date:  2007-05-04       Impact factor: 6.261

7.  AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer.

Authors:  Krishna M Vasudevan; David A Barbie; Michael A Davies; Rosalia Rabinovsky; Chontelle J McNear; Jessica J Kim; Bryan T Hennessy; Hsiuyi Tseng; Panisa Pochanard; So Young Kim; Ian F Dunn; Anna C Schinzel; Peter Sandy; Sebastian Hoersch; Qing Sheng; Piyush B Gupta; Jesse S Boehm; Jan H Reiling; Serena Silver; Yiling Lu; Katherine Stemke-Hale; Bhaskar Dutta; Corwin Joy; Aysegul A Sahin; Ana Maria Gonzalez-Angulo; Ana Lluch; Lucia E Rameh; Tyler Jacks; David E Root; Eric S Lander; Gordon B Mills; William C Hahn; William R Sellers; Levi A Garraway
Journal:  Cancer Cell       Date:  2009-07-07       Impact factor: 31.743

8.  BAYESIAN SPARSE GRAPHICAL MODELS FOR CLASSIFICATION WITH APPLICATION TO PROTEIN EXPRESSION DATA.

Authors:  Veerabhadran Baladandayuthapani; Rajesh Talluri; Yuan Ji; Kevin R Coombes; Yiling Lu; Bryan T Hennessy; Michael A Davies; Bani K Mallick
Journal:  Ann Appl Stat       Date:  2014       Impact factor: 2.083

Review 9.  Linking molecular diagnostics to molecular therapeutics: targeting the PI3K pathway in breast cancer.

Authors:  Gordon B Mills; Elise Kohn; Yiling Lu; Astrid Eder; Xianjun Fang; Hongwei Wang; Robert C Bast; Joe Gray; Robert Jaffe; Gabriel Hortobagyi
Journal:  Semin Oncol       Date:  2003-10       Impact factor: 4.929

10.  Serial dilution curve: a new method for analysis of reverse phase protein array data.

Authors:  Li Zhang; Qingyi Wei; Li Mao; Wenbin Liu; Gordon B Mills; Kevin Coombes
Journal:  Bioinformatics       Date:  2009-01-28       Impact factor: 6.937

View more
  10 in total

1.  Statistical Contributions to Bioinformatics: Design, Modeling, Structure Learning, and Integration.

Authors:  Jeffrey S Morris; Veerabhadran Baladandayuthapani
Journal:  Stat Modelling       Date:  2017-06-15       Impact factor: 2.039

2.  Bayesian data integration and variable selection for pan-cancer survival prediction using protein expression data.

Authors:  Arnab Kumar Maity; Anirban Bhattacharya; Bani K Mallick; Veerabhadran Baladandayuthapani
Journal:  Biometrics       Date:  2019-10-03       Impact factor: 2.571

3.  Classification and prediction for multi-cancer data with ultrahigh-dimensional gene expressions.

Authors:  Li-Pang Chen
Journal:  PLoS One       Date:  2022-09-15       Impact factor: 3.752

4.  BAYESIAN SPARSE GRAPHICAL MODELS FOR CLASSIFICATION WITH APPLICATION TO PROTEIN EXPRESSION DATA.

Authors:  Veerabhadran Baladandayuthapani; Rajesh Talluri; Yuan Ji; Kevin R Coombes; Yiling Lu; Bryan T Hennessy; Michael A Davies; Bani K Mallick
Journal:  Ann Appl Stat       Date:  2014       Impact factor: 2.083

5.  Using multivariate mixed-effects selection models for analyzing batch-processed proteomics data with non-ignorable missingness.

Authors:  Jiebiao Wang; Pei Wang; Donald Hedeker; Lin S Chen
Journal:  Biostatistics       Date:  2019-10-01       Impact factor: 5.899

6.  Bayesian networks established functional differences between breast cancer subtypes.

Authors:  Lucía Trilla-Fuertes; Angelo Gámez-Pozo; Jorge M Arevalillo; Rocío López-Vacas; Elena López-Camacho; Guillermo Prado-Vázquez; Andrea Zapater-Moros; Mariana Díaz-Almirón; María Ferrer-Gómez; Hilario Navarro; Paolo Nanni; Pilar Zamora; Enrique Espinosa; Paloma Maín; Juan Ángel Fresno Vara
Journal:  PLoS One       Date:  2020-06-11       Impact factor: 3.240

7.  Fast Bayesian inference in large Gaussian graphical models.

Authors:  Gwenaël G R Leday; Sylvia Richardson
Journal:  Biometrics       Date:  2019-05-06       Impact factor: 2.571

8.  NExUS: Bayesian simultaneous network estimation across unequal sample sizes.

Authors:  Priyam Das; Christine B Peterson; Kim-Anh Do; Rehan Akbani; Veerabhadran Baladandayuthapani
Journal:  Bioinformatics       Date:  2020-02-01       Impact factor: 6.937

9.  Bayesian Structure Learning in Multi-layered Genomic Networks.

Authors:  Min Jin Ha; Francesco Claudio Stingo; Veerabhadran Baladandayuthapani
Journal:  J Am Stat Assoc       Date:  2020-07-24       Impact factor: 5.033

10.  Integrative bayesian network analysis of genomic data.

Authors:  Yang Ni; Francesco C Stingo; Veerabhadran Baladandayuthapani
Journal:  Cancer Inform       Date:  2014-09-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.